AGN
$244.39
Allergan Plc
$5.76
2.41%
AGN
Earnings Whisper ®
N/A
2nd Quarter June 2017
Consensus:  $3.98
Revenue:  $3.93 Bil
Tuesday
Aug 8
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AGN reports earnings?
Beat
Meet
Miss

Where is AGN's stock price going from here?
Up
Flat
Down
Stock chart of AGN
Analysts
Summary of analysts' recommendations for AGN
Score
Grade
Pivots
Resistance
$252.90
$248.80
$246.60

$242.50

Support
$240.30
$236.20
$234.00
Tweet
Growth
Description
Allergan, Inc. is a provider of eye care and specialty pharmaceutical products throughout the world with products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets. Its worldwide consolidated revenues are principally generated by prescription and non-prescription pharmaceutical products in the areas of ophthalmology and skin care, neurotoxins, intraocular lenses and other ophthalmic surgical products, and contact lens care products.